Proteasome function in the aging retina
蛋白酶体在老化视网膜中的功能
基本信息
- 批准号:7117222
- 负责人:
- 金额:$ 35.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-15 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The proposed work focuses on the proteasome. This enzyme complex is responsible for most cell protein degradation, including fundamental processes responsible for cell viability and function. We will ask if age-related defects in proteasome function disrupt the function of the retinal pigment epithelium (RPE), and what are the consequences of reduced proteasome function. One focus will be on defining the role of the proteasome in the RPE, where two roles are considered. Since proteasome controls processes that are essential for cell survival, a loss of proteasome function could cause RPE cell death through the accumulation of dysfunctional proteins or the disruption of critical cell pathways. Alternatively, if proteasome participates in the degradation of phagocytosed rod outer segments (ROS), decreased proteasome function could contribute to diminished processing of ROS proteins. A second focus will be to elucidate the biochemical mechanism responsible for the age-dependent loss in proteasome function. The following Aims will be pursued: (1) Define the proteolytic capabilities of the proteasome in the RPE. (a) Define the role of the proteasome in the degradation of phagocytosed rod outer segments. (b) Determine the effect of stressors on RPE proteasome function. (2) Determine age-related changes in retinal proteasome function. (a) Quantify age-related alterations in proteasome function and expression. (b) Identify post-translational modifications in proteasomal subunits. Our investigative approach will include a range of techniques in biochemistry, cell biology, immunology, molecular biology, and proteomics using rodent models of aging, transgenic mice, and cultured cells. Little information is known about proteasome function in the retina, so these studies will provide an important contribution to basic retinal physiology and the effects of aging.
DESCRIPTION (provided by applicant): The proposed work focuses on the proteasome. This enzyme complex is responsible for most cell protein degradation, including fundamental processes responsible for cell viability and function. We will ask if age-related defects in proteasome function disrupt the function of the retinal pigment epithelium (RPE), and what are the consequences of reduced proteasome function. One focus will be on defining the role of the proteasome in the RPE, where two roles are considered. Since proteasome controls processes that are essential for cell survival, a loss of proteasome function could cause RPE cell death through the accumulation of dysfunctional proteins or the disruption of critical cell pathways. Alternatively, if proteasome participates in the degradation of phagocytosed rod outer segments (ROS), decreased proteasome function could contribute to diminished processing of ROS proteins. A second focus will be to elucidate the biochemical mechanism responsible for the age-dependent loss in proteasome function. The following Aims will be pursued: (1) Define the proteolytic capabilities of the proteasome in the RPE. (a) Define the role of the proteasome in the degradation of phagocytosed rod outer segments. (b) Determine the effect of stressors on RPE proteasome function. (2) Determine age-related changes in retinal proteasome function. (a) Quantify age-related alterations in proteasome function and expression. (b) Identify post-translational modifications in proteasomal subunits. Our investigative approach will include a range of techniques in biochemistry, cell biology, immunology, molecular biology, and proteomics using rodent models of aging, transgenic mice, and cultured cells. Little information is known about proteasome function in the retina, so these studies will provide an important contribution to basic retinal physiology and the effects of aging.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah Ann Ferrington其他文献
Deborah Ann Ferrington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah Ann Ferrington', 18)}}的其他基金
Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H
破译与 ARMS2/HTRA1 和补体因子 H 的高风险 AMD 基因型相关的机制
- 批准号:
10581822 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H
破译与 ARMS2/HTRA1 和补体因子 H 的高风险 AMD 基因型相关的机制
- 批准号:
10707245 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Immunoproteasome: A key component of the cellular stress response
免疫蛋白酶体:细胞应激反应的关键组成部分
- 批准号:
7510560 - 财政年份:2008
- 资助金额:
$ 35.69万 - 项目类别:
Training Grant: Functional Protemics of Aging
培训补助金:衰老的功能蛋白质学
- 批准号:
8850365 - 财政年份:2008
- 资助金额:
$ 35.69万 - 项目类别:
Training Grant: Functional Protemics of Aging
培训补助金:衰老的功能蛋白质学
- 批准号:
8475023 - 财政年份:2008
- 资助金额:
$ 35.69万 - 项目类别:
Training Grant: Functional Protemics of Aging
培训补助金:衰老的功能蛋白质学
- 批准号:
8792316 - 财政年份:2008
- 资助金额:
$ 35.69万 - 项目类别:
Immunoproteasome: A key component of the cellular stress response
免疫蛋白酶体:细胞应激反应的关键组成部分
- 批准号:
7685277 - 财政年份:2008
- 资助金额:
$ 35.69万 - 项目类别:
Proteomics of altered protein in macular degeneration
黄斑变性中蛋白质改变的蛋白质组学
- 批准号:
6833434 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
Proteomics of altered protein in macular degeneration
黄斑变性中蛋白质改变的蛋白质组学
- 批准号:
6992685 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
Proteomics of altered protein in macular degeneration
黄斑变性中蛋白质改变的蛋白质组学
- 批准号:
6727783 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
- 批准号:31970691
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
- 批准号:31900527
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
姜黄素与TRAIL的协同抗肿瘤机制研究
- 批准号:31101223
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
- 批准号:81100502
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CRMP2 Phosphorylation: A Novel Target for Alzheimer's Disease?
CRMP2 磷酸化:阿尔茨海默病的新靶标?
- 批准号:
10282421 - 财政年份:2021
- 资助金额:
$ 35.69万 - 项目类别:
Exploratory Research on HIV Contribution to Heart and Lung Comorbidities
HIV 对心肺合并症影响的探索性研究
- 批准号:
10012373 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
Exploratory Research on HIV Contribution to Heart and Lung Comorbidities
HIV 对心肺合并症影响的探索性研究
- 批准号:
10569641 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
Exploratory Research on HIV Contribution to Heart and Lung Comorbidities
HIV 对心肺合并症影响的探索性研究
- 批准号:
10343825 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
Redox Regulation of Cysteine-Dependent Peroxidases and Signal Transduction Pathways
半胱氨酸依赖性过氧化物酶和信号转导途径的氧化还原调节
- 批准号:
10548745 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
Oxidation of K+ channels mediates an amyloidogenic pathway common to Alzheimer's disease and TBI
K 通道氧化介导阿尔茨海默病和 TBI 常见的淀粉样蛋白生成途径
- 批准号:
10532772 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:
Oxidation of K+ channels mediates an amyloidogenic pathway common to Alzheimer's disease and TBI
K 通道氧化介导阿尔茨海默病和 TBI 常见的淀粉样蛋白生成途径
- 批准号:
10062467 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:
Oxidation of K+ channels mediates an amyloidogenic pathway common to Alzheimer's disease and TBI
K 通道氧化介导阿尔茨海默病和 TBI 常见的淀粉样蛋白生成途径
- 批准号:
10317081 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:
Clu forms a dynamic new ribonucleoprotein particle directly involved in mitochondrial function
Clu 形成直接参与线粒体功能的动态新核糖核蛋白颗粒
- 批准号:
10163877 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:
Clu forms a dynamic new ribonucleoprotein particle directly involved in mitochondrial function
Clu 形成直接参与线粒体功能的动态新核糖核蛋白颗粒
- 批准号:
10434693 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:














{{item.name}}会员




